Average life expectancy of heterozygous beta thalassemic subjects.
In order to define the lifespan of heterozygous beta thalassemic subjects as compared to non thalassemic subjects, the authors prospectively studied all patients deceased during a period of 76 months at St. Camillo Hospital of Comacchio (Ferrara), located in the Po delta, a region with high prevalence of thalassemia minor. No statistically significant differences were found in the average life expectancy between the thalassemic and non thalassemic groups.
Gallerani
M
M
Divisione di Medicina, Ospedale S. Camillo, Regione Emilia Romagna, Codigoro (FE), Italy.
Cicognani
I
I
Ballardini
P
P
Savelli
S
S
Martinelli
L
L
Ricci
A
A
Coletti
M
M
Faggioli
M
M
Stabellini
G
G
D006579:Heterozygote; D006801:Humans; D008017:Life Expectancy; D011446:Prospective Studies; D013789:Thalassemia / Q000235:genetics* / Q000401:mortality